CEO
Symbiotic Research, LLC
Mt. Olive, New Jersey
1991 BS Chemistry/ minor Biochemistry, University of Arkansas, Fayetteville AR.
2001, Ph.D. degree in Environmental Analytical Chemistry, Rutgers University, Cook College, New Brunswick, New Jersey
1993-2001: Research Chemist, American Cyanamid Global Research Center, Princeton NJ (a Pfizer company).
2001-2009: Group Leader, Taxolog, Inc, a biopharmaceutical company.
2009-Present: Founder and CEO, Symbiotic Research; a New Jersey based GLP Regulatory Sciences R&D CRO conducting FDA and EPA compliant studies.
Dan has published and presented in the areas of drug metabolism, structure elucidation, residue and bioanalysis by UHPLC-MS-TOF as well as CE-MS-TOF.
Dan has been published in JPBA, Journal of Chromatography, Electrophoresis, JAOAC and Journal of Pesticide Science. Per invitation from US-EPA regulatory bodies, Dan has contributed a chapter on Application of Capillary Electrophoresis to Pesticide Analysis to the Encyclopedia of Agrochemicals.
In 2014, Dan was hired by the International Atomic Energy Agency, as an “Expert Lecturer” to support the agency in helping specific developing countries to build self-sustaining analytical testing capabilities using LCMS.
In 2017, Dan sold Symbiotic Research to Tentamus GmbH.
In 2018, Dan acquired Genesis Midwest to enable Symbiotic to provide in-life and analytical package study services to its global Animal Health and Agrochemical clients.
Application of Accurate Mass Spectrometry for Nitrosamine Impurities in Metformin
Monday, October 23, 2023
12:30 PM – 1:15 PM ET